[
  {
    "ts": null,
    "headline": "EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)",
    "summary": "mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the European Union, subject to authorization by the ...",
    "url": "https://finnhub.io/api/news?id=106cadecbe554335ee4e445fc87a93bd612fbdd0649a5d204c182a546d1c29dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765800000,
      "headline": "EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)",
      "id": 137793436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the European Union, subject to authorization by the ...",
      "url": "https://finnhub.io/api/news?id=106cadecbe554335ee4e445fc87a93bd612fbdd0649a5d204c182a546d1c29dc"
    }
  },
  {
    "ts": null,
    "headline": "3 Cash-Burning Stocks We Steer Clear Of",
    "summary": "Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.",
    "url": "https://finnhub.io/api/news?id=bb848631988fe27e5f9184637b50482ac59aedc0fdb698f7fa54d6486dec160f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765773640,
      "headline": "3 Cash-Burning Stocks We Steer Clear Of",
      "id": 137793437,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.",
      "url": "https://finnhub.io/api/news?id=bb848631988fe27e5f9184637b50482ac59aedc0fdb698f7fa54d6486dec160f"
    }
  }
]